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LETTER TO THE EDITOR
EDITOR The best treatment for cirrhotic hyper-
splenism is still unknown. Both splenectomy and
transcatheter splenic artery embolization have shown
contradictory clinical results. We report our experience
with the management ofhypersplenism in 114 patients
with liver cirrhosis.
The patients were divided in three groups in rela-
tion to treatment: I (splenectomy, 20 pts),II (proximal
or peripheral splenic embolization, 48 pts), and III
(conservative therapy, 46 pts). All groups were identi-
cal in sex, age, grade of hypersplenism (platelet count
36 x 109/L to 75 x 109/L), and Child-Pugh’s Class of
liver cirrhosis.
The results showed that splenectomy had rates of
mortality and complications (5% and 10%) at least
no higher than splenic embolization (10% and 19%).
Improvement in hypersplenism to year of follow-up
was seen in 100% of patients in Group I vs 16% in
Group II.
The survival rates did not differ significantly be-
tween all patients, however. In Groups I, II, and III,
the 5-yr survival for Class A cirrhosis was 82%, 53%,
and 81%, for Class B 70%, 30%, and 56%, respectively.
The 3-yr survival rates for Class C cirrhosis were 33%,
14%, and 33%. The causes ofdeath were identical in all
groups, without prevalence ofvariceal bleeding among
conservatively treated patients.
These results show that splenic embolization is
more dangerous and less effective than traditional sple-
nectomy for control of cirrhotic hypersplenism. How-
ever, both treatments do not prolong survival of pa-
tients if compared with conservative therapy.
Pavel G. Tarazov, MD
Alexej A. Polykarpov, MD
Division of Angio/Interventional,
St. Petersburg Research Institute of
Roentgenology and Radiation Therapy,
Pesochny-2, St. Petersburg, 189646 Russia.
Address for correspondence: P.G. Tarazov, MD Res Inst Roent-
genol ul Leningradskaja 70/4 Pesochny-2 St Petersburg 189646 Rus-
sia Phone: (812)437-8766 Fax: (812)437-5600.
55